Bradley Vince

720 total citations
29 papers, 452 citations indexed

About

Bradley Vince is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health and Psychiatry and Mental health. According to data from OpenAlex, Bradley Vince has authored 29 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Psychiatry and Mental health. Recurrent topics in Bradley Vince's work include Opioid Use Disorder Treatment (7 papers), Attention Deficit Hyperactivity Disorder (5 papers) and Treatment of Major Depression (5 papers). Bradley Vince is often cited by papers focused on Opioid Use Disorder Treatment (7 papers), Attention Deficit Hyperactivity Disorder (5 papers) and Treatment of Major Depression (5 papers). Bradley Vince collaborates with scholars based in United States, Canada and France. Bradley Vince's co-authors include Debra Kelsh, Azmi Nasser, Yongzhen Liu, Michelle R. Lofwall, Jermaine D. Jones, Sandra D. Comer, Mark K. Greenwald, Christian Heidbreder, Naama Levy‐Cooperman and Paul J. Fudala and has published in prestigious journals such as Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy and Journal of the American Academy of Child & Adolescent Psychiatry.

In The Last Decade

Bradley Vince

29 papers receiving 433 citations

Peers

Bradley Vince

PHEOH

EPIDE

APM

PMH

Ulrike Ebert Germany

Michel Mallaret France

Simona De Gregori Italy

Daniel T. Barratt Australia

A BERTOLINI Italy

Dora H. Lin United States

Paula Burger United States

Jocelyne Chabert Switzerland

Nancy Janiczek United States

Fred Schobben Netherlands

Ulrike Ebert Germany

Bradley Vince

54 ×0.5

PHEOH

50 ×0.6

EPIDE

67 ×0.9

36 ×0.6

APM

53 ×0.9

PMH

Citations per year, relative to Bradley Vince Bradley Vince (= 1×) peers Ulrike Ebert

Countries citing papers authored by Bradley Vince

Since Specialization

Citations

This map shows the geographic impact of Bradley Vince's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bradley Vince with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bradley Vince more than expected).

Fields of papers citing papers by Bradley Vince

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bradley Vince. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bradley Vince. The network helps show where Bradley Vince may publish in the future.

Co-authorship network of co-authors of Bradley Vince

This figure shows the co-authorship network connecting the top 25 collaborators of Bradley Vince. A scholar is included among the top collaborators of Bradley Vince based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bradley Vince. Bradley Vince is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shram, Megan J., Beatrice Setnik, Lynn R. Webster, et al.. (2022). Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidate. Current Medical Research and Opinion. 38(7). 1237–1250. 7 indexed citations

OGASAWARA, K., Bradley Vince, Christine Xu, et al.. (2020). A phase I study of the effect of repeated oral doses of pantoprazole on the pharmacokinetics of a single dose of fedratinib in healthy male subjects. Cancer Chemotherapy and Pharmacology. 85(5). 995–1001. 8 indexed citations

Kankam, Martin, Jeffrey Price, Josée Michaud, et al.. (2020). Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy Subjects. Advances in Therapy. 37(5). 2373–2389. 1 indexed citations

Tarabar, Sanela, Debra Kelsh, Bradley Vince, et al.. (2020). Phase I Pharmacokinetic Study of Fixed-Dose Combinations of Ibuprofen and Acetaminophen in Healthy Adult and Adolescent Populations. Drugs in R&D. 20(1). 23–37. 10 indexed citations

O’Malley, Stephanie S., Megan J. Shram, Naama Levy‐Cooperman, et al.. (2020). Interaction of Ethanol and Oral ANS‐6637, a Selective ALDH2 Inhibitor in Males: A Randomized, Double‐Blind, Placebo‐Controlled, Single‐Ascending Dose Cohort Study. Alcoholism Clinical and Experimental Research. 44(9). 1885–1895. 6 indexed citations

Mendell, Jeanne, Naama Levy‐Cooperman, Bradley Vince, et al.. (2019). Abuse potential of mirogabalin in recreational polydrug users. Therapeutic Advances in Drug Safety. 10. 584377984–584377984. 13 indexed citations

Jones, Jermaine D., Shanna Babalonis, Ronald N. Marcus, et al.. (2019). A randomized, double‐blind, placebo‐controlled study of the kappa opioid receptor antagonist, CERC‐501, in a human laboratory model of smoking behavior. Addiction Biology. 25(4). e12799–e12799. 23 indexed citations

Barrett, Andrew C., et al.. (2019). Pharmacokinetics and Abuse Potential of Asalhydromorphone, a Novel Prodrug of Hydromorphone, After Intranasal Administration in Recreational Drug Users. Pain Medicine. 21(3). 511–520. 3 indexed citations

Pathak, Sanjeev, Bradley Vince, Debra Kelsh, et al.. (2018). Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial. The Journal of Clinical Pharmacology. 59(2). 206–217. 8 indexed citations

10.

Pathak, Sanjeev, Bradley Vince, Debra Kelsh, et al.. (2018). Abuse Potential of Samidorphan: A Phase I, Oxycodone‐, Pentazocine‐, Naltrexone‐, and Placebo‐Controlled Study. The Journal of Clinical Pharmacology. 59(2). 218–228. 11 indexed citations

11.

Steinberg, Alexandra, Bradley Vince, Yun‐Jung Choi, et al.. (2016). The Pharmacodynamics, Pharmacokinetics, and Safety of Arhalofenate in Combination with Febuxostat When Treating Hyperuricemia Associated with Gout. The Journal of Rheumatology. 44(3). 374–379. 33 indexed citations

12.

Shusterman, Neil H., et al.. (2016). (443) Evaluation of the clinical abuse potential of Opana ER versus oxymorphone HCl powder. Journal of Pain. 17(4). S85–S85. 2 indexed citations

13.

Nasser, Azmi, Mark K. Greenwald, Bradley Vince, et al.. (2015). Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder. Journal of Clinical Psychopharmacology. 36(1). 18–26. 53 indexed citations

14.

Vince, Bradley, John M. Hill, Eric Lawitz, et al.. (2014). A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4. Journal of Hepatology. 60(5). 920–927. 19 indexed citations

15.

Joseph, David, Bradley Vince, Lynn R. Webster, et al.. (2014). Effect of Steady-State Faldaprevir on the Pharmacokinetics of Steady-State Methadone and Buprenorphine-Naloxone in Subjects Receiving Stable Addiction Management Therapy. Antimicrobial Agents and Chemotherapy. 59(1). 498–504. 4 indexed citations

16.

Chyung, Yung, Bradley Vince, Ryan Iarrobino, et al.. (2014). A phase 1 study investigating DX-2930 in healthy subjects. Annals of Allergy Asthma & Immunology. 113(4). 460–466.e2. 44 indexed citations

17.

Lawitz, Eric, John M. Hill, Bradley Vince, et al.. (2013). 847 ACH-2684 DEMONSTRATES POTENT VIRAL SUPPRESSION IN GENOTYPE 1 HEPATITIS C PATIENTS WITH AND WITHOUT CIRRHOSIS: SAFETY, PHARMACOKINETIC, AND VIRAL KINETIC ANALYSIS. Journal of Hepatology. 58. S347–S347. 5 indexed citations

18.

Kramer, William G., et al.. (2013). Comparison of the pharmacokinetics (PK) of galeterone novel oral formulations.. Journal of Clinical Oncology. 31(15_suppl). e16075–e16075. 6 indexed citations

19.

Kollins, Scott H., Frank A. López, Bradley Vince, et al.. (2011). Psychomotor Functioning and Alertness with Guanfacine Extended Release in Subjects with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 21(2). 111–120. 45 indexed citations

20.

Lawitz, E.J., Bradley Vince, Nicole Grunenberg, et al.. (2010). 2008 DOSE-RANGING, THREE-DAY MONOTHERAPY STUDY OF THE HCV NS3 PROTEASE INHIBITOR GS-9256. Journal of Hepatology. 52. S466–S467. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact